Evidence map›Paper›PMID 39977586›Full record

ReviewChemistry & biodiversity2025

Chemical Components of the Dried Latex of Euphorbia resinifera Berg and Its Medicinal Features.

Doaa Hammad, El-Mahdi Ourhzif, Salha Hamri, Hafid Abderrafia, Mostafa Khouili, Maria Dolors Pujol

Abstract readReview
In one paragraph

Review in Chemistry & biodiversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Doaa HammadLaboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.
El-Mahdi OurhzifCentre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Salha HamriLaboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni-Mellal, Morocco.
Hafid AbderrafiaLaboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni-Mellal, Morocco.
Mostafa KhouiliLaboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni-Mellal, Morocco.
Maria Dolors PujolLaboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-1061-034X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A great deal of research has been carried out on the latex of Euphorbia resinifera Berg, which is an important source of several compounds of therapeutic and medicinal interest. Extraction, synthesis, and hemi synthesis pathways continue to reveal the existence of other new products with anticancer, antioxidant, antidiuretic, and antimalarial effects. Despite the huge number of existing drugs, plants are still used mainly as a treatment for pain and as a source of inspiration for new drugs. In this study, the different components of the dried latex of this plant and their effects on human health have been studied. It should be noted that resiniferatoxin, with a pain-relieving activity superior to capsaicin, has proven to be effective for the treatment of osteoarthritis, a painful disease with no specific treatment.

Indexed as

AnalgesicsEuphorbiaLatexAntioxidantsDiterpenesHumansOsteoarthritisAnalgesicsAntioxidantsDiterpenesLatexresiniferatoxinantibacterialanti‐inflammatory activitiesantitumorcytotoxicityethnomedicinal usesEuphorbiaceaeEuphorbia resiniferalatexosteoarthritisresiniferatoxin

Identifiers

PMID39977586
PMCPMC12270358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.